Pharma Mar SAU (PHMR)

76.180
-2.000(-2.56%)
  • Volume:
    72,518
  • Bid/Ask:
    76.300/76.300
  • Day's Range:
    75.360 - 78.120
  • Type:Equity
  • Market:Spain
  • ISIN:ES0169501022

PHMR Overview

Prev. Close
76.18
Day's Range
75.36-78.12
Revenue
221.78M
Open
77.38
52 wk Range
66.7-148
EPS
4.95
Volume
72,518
Market Cap
1.38B
Dividend (Yield)
0.60
(0.77%)
Average Vol. (3m)
96,953
P/E Ratio
15.60
Beta
-0.15
1-Year Change
-31.3%
Shares Outstanding
18,112,907
Next Earnings Date
Jul 29, 2021
What is your sentiment on Pharma Mar SAU?
or
Market is currently closed. Voting is open during market hours.

Pharma Mar SAU News

Pharma Mar SAU Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellNeutral
Technical IndicatorsStrong SellBuyStrong SellBuySell
SummaryStrong SellNeutralStrong SellNeutralNeutral

Pharma Mar SAU Company Profile

Pharma Mar SAU Company Profile

Employees
443
Market
Spain

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops clinical-stage programs, including PM184 and PM14. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.

Read More
  • Carballo en antena3 diciendo aplidin, en julio a 200 xdXD!!
    0
    • Menudo desastre de valor. Hace 3 meses en 114. Ahora en 77. Eso es un 32% de depreciación. Que en los tiempos que corren una farmaceutica pierda semejante valor en bolsa con un medicamento que supuestamente es tratamiento eficaz contra el Covid, habla muy mal de la compañía. Engaño de valor.
      0
      • Compara el valor a 1 de enero de los ultimos años y nos cuentas. Si quieres dinero rapido vete a las criptos, no a las pharmas.
        1
      • esq una bio española... compra ctxr!
        0
    • fase 2 aprobada en UK. en abril 200€
      0
      • Visionario!!
        0
      • Ojala…
        0
    • Deberemos esperar el resultado de los ensayos clínicos en fase III de Aplidin contra Covid-19.
      0
      • pasa que se va a valores ciclicos
        0
        • Volvera
          0
      • Que pasa aqui?!?
        0
        • 1
          0
          • at nasdad????
            0
            • at 125
              0
              • este titulo esta muerto
                0
                • Up up up
                  1
                  • buy buy buy
                    0
                    • at 150e
                      2
                      • Buenos dias a todos.Alguien puede decirme si estas acciones van a dar dividendos este mes de febrero? Me parecio leer algo del proximo lunes 22. Y en segundo lugar, creeis que la accion puede subir entre 120 y 130 antes de que acabe este mes de febrero?. Muchas gracias!!
                        2
                        • cuando los den en madrid, aqui tambien, no hay otra...
                          0
                      • Esto ya me suena haberlo visto. Es la acción con más tramposos del IBEX. Típica jugada de OTC. La bajo a los infiernos e inmediatamente después la subo. Y la CN MV mirando al sobre- cito.....VERGÚENZA DE PÁIS
                        2
                        • preparate a verla a mas de 150 rapidito...
                          1
                      • at 150e
                        1
                        • when?
                          0
                        • Hola Juan Carlos,el maximo de record al que llego la accion es de 148 e. A que te refieres al poner lo de 150 e ??. Gracias. Saludos
                          0
                        • QUIM RIBERAestaba pensando en euros...
                          0
                      • Hombro-cabeza-hombro?
                        1
                        • y tiro porque me toca
                          0
                      • TP 150$
                        0
                        • correcting?
                          0
                          • with a p/e of 13, and an antiviral that can solve covid problem, this company is going to the moon
                            0
                            • Naked Brand stock 🚀
                              0
                              • PharmaMar's antiviral is 100 times more effective against Covid-19 than other treatments, reducing its viral load by almost 100%. HALLELUJAH !!!
                                1
                                • Ehang
                                  0
                                  • at 150e
                                    1
                                    • https://www.eleconomista.es/empresas-finanzas/noticias/11012480/01/21/El-Aplidin-el-antiviral-de-PharmaMar-es-cien-veces-mas-potente-que-el-tratamiento-que-se-esta-usando-para-el-covid19.html
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.